1-4 of 4
Xiuhua Zhao
Close
Sort by
Journal Articles

Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma

Clinical Trials & Observations
Rachid C. Baz, Thomas G. Martin, III, Hui-Yi Lin, Xiuhua Zhao, Kenneth H. Shain, Hearn J. Cho, Jeffrey L. Wolf, Anuj Mahindra, Ajai Chari, Daniel M. Sullivan, Lisa A. Nardelli, Kenneth Lau, Melissa Alsina, Sundar Jagannath
Journal: Blood
Blood (2016) 127 (21): 2561–2568.
https://doi.org/10.1182/blood-2015-11-682518
Published: 2016
Includes: Supplemental data
Journal Articles

Pomalidomide, Cyclophosphamide, and Dexamethasone Is Superior to Pomalidomide and Dexamethasone in Relapsed and Refractory Myeloma: Results of a Multicenter Randomized Phase II Study

Rachid Baz, MD, Thomas G. Martin, MD, Melissa Alsina, MD, Kenneth H. Shain, MD PhD, Hearn J. Cho, MD PhD, Jeffrey L Wolf, MD, Anuj Mahindra, MD, Ajai Chari, MD, Daniel M Sullivan, MD, Lisa A Nardelli, BS, CCRP, Kenneth Lau, BA, Xiuhua Zhao, Hui-Yi Lin, PhD, Sundar Jagannath, MD
Journal: Blood
Blood (2014) 124 (21): 303.
https://doi.org/10.1182/blood.V124.21.303.303
Published: 2014
Journal Articles

A Phase II Study of CLAG Regimen in Combination with Imatinib Mesylate in relapsed or Refractory Acute Myeloid Leukemia

Rami S. Komrokji, MD, Javier Pinilla-Ibarz, MD, PhD, Daohai Yu, Ph.D, Lisa Nardelli, Christopher Cubitt, Xiuhua Zhao, Hugo F. Fernandez, MD, Alan F List, MD, Jeffrey E. Lancet, MD
Journal: Blood
Blood (2011) 118 (21): 2604.
https://doi.org/10.1182/blood.V118.21.2604.2604
Published: 2011
Journal Articles

Combined Inhibition of CDK and PI3K/Akt Pathways Induces Apoptosis of Mantle Cell Lymphoma.

Subhra Mohapatra, PhD, Baoky Chu, BS, Xiuhua Zhao, MS, Jianguo Tao, MD, Eduardo Sotomayor, MD, W. Jack Pledger, PhD
Journal: Blood
Blood (2007) 110 (11): 1384.
https://doi.org/10.1182/blood.V110.11.1384.1384
Published: 2007